Expression profiling of microRNAs in RAW264.7 cells treated with a combination of tumor necrosis factor alpha and RANKL during osteoclast differentiation
Authors:
- 18 October 2012
- journal article
- Published by Wiley in Journal of Periodontal Research
- Vol. 48 (3) , 373-385
Abstract
Background and Objective: Tumor necrosis factor alpha (TNF‐α), a cytokine involved in the pathogenesis of periodontal disease, induces osteoclast differentiation and indirectly promotes alveolar bone resorption. We investigated TNF‐α‐regulated osteoclast differentiation, focusing on microRNAs. MicroRNAs are small, noncoding RNAs that are involved in various biological processes, including cellular differentiation, proliferation and apoptosis. Aside from miR‐21, miR‐155 and miR‐223, the identities of the microRNAs that play roles in osteoclast differentiation are unknown. Notably, no previous studies have reported the expression profiling of microRNAs during TNF‐α‐regulated osteoclast differentiation.Material and Methods: We used microarrays to screen the levels of expression of mature microRNAs in RAW264.7 cells treated with a combination of TNF‐α and RANKL, or RANKL alone for 0, 24 or 82 h during osteoclast formation. We validated the results of the microarray analyses through quantitative RT‐PCR analyses of representative microRNAs in RAW264.7 cells and murine bone marrow macrophages.Results: During osteoclast formation, the expression of 44 mature microRNAs differed by more than twofold between untreated cells and cells treated with a combination of TNF‐α and RANKL, and the expression of 52 mature microRNAs differed upon RANKL treatment. According to quantitative RT‐PCR analyses, miR‐378 was upregulated and miR‐223 was downregulated during osteoclast formation. Furthermore, miR‐21, miR‐29b, miR‐146a, miR‐155 and miR‐210 were highly expressed during osteoclast differentiation in TNF‐α/RANKL‐treated cells compared with RANKL‐treated cells.Conclusions: These results suggest that miR‐223 and miR‐378 may play important roles in osteoclastogenesis, and that miR‐21, miR‐29b, miR‐146a, miR‐155 and miR‐210 are involved in TNF‐α‐regulated osteoclast differentiation.Keywords
Funding Information
- Keiryokai Research Foundation (97, 21791830, 23593042)
- Ministry of Education, Culture, Sports, Science and Technology, Japan
This publication has 50 references indexed in Scilit:
- MicroRNA control of bone formation and homeostasisNature Reviews Endocrinology, 2012
- Mammalian microRNAs predominantly act to decrease target mRNA levelsNature, 2010
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersNature Cell Biology, 2008
- A microRNA signature for a BMP2-induced osteoblast lineage commitment programProceedings of the National Academy of Sciences, 2008
- MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expressionProceedings of the National Academy of Sciences, 2007
- Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNature Cell Biology, 2007
- MicroRNA-155 is induced during the macrophage inflammatory responseProceedings of the National Academy of Sciences, 2007
- NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responsesProceedings of the National Academy of Sciences of the United States of America, 2006
- MicroRNA expression profiles classify human cancersNature, 2005
- Osteoclast differentiation and activationNature, 2003